Difficulty: Medium
Average Score: 87%
Practice
A patient with Alzheimer's disease is taking an acetyl cholinesterase inhibitor specifically approved for that indication, primarily because it is quite lipophilic and so enters the CNS well. Which of the following drugs is the patient most likely receiving?
Correct answer
A
Rationale
Donepezil is lipophilic, allowing it to cross the blood-brain barrier effectively, making it suitable for Alzheimer's by increasing CNS acetylcholine levels.